The FDA approved xarelto (also known as “rivaroxaban”) in 2011 as an alternate drug product to other prescriptions that thin the blood. Those who suffer from atrial fibrillation are at extra risk for blood clots that might lead to a stroke. Blood clots are also a risk after major joint reconstruction surgery, such as hip or knee replacement. Blood thinners are the answer. Drugs such as the newer xarelto and the older warfarin both work as an anti-coagulant – that is, to prevent the blood Read More +